MedTrace Logo

Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer

NCT00897871 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2013-08-12

No results posted yet for this study

Summary

RATIONALE: Studying samples of blood in the laboratory from young patients with cancer may help doctors learn how carboplatin, cyclophosphamide, and etoposide affect the body and how patients will respond to treatment.

PURPOSE: This laboratory study is evaluating the side effects and how well anticancer drugs work in very young patients with cancer.

Conditions

  • Unspecified Childhood Solid Tumor, Protocol Specific

Interventions

DRUG

carboplatin

DRUG

cyclophosphamide

DRUG

etoposide phosphate

GENETIC

gene expression analysis

GENETIC

polymorphism analysis

OTHER

pharmacological study

Sponsors & Collaborators

  • Children's Cancer and Leukaemia Group

    lead OTHER

Principal Investigators

  • Gareth Veal · University of Newcastle Upon-Tyne

Eligibility

Max Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28

Countries

  • Ireland
  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00897871 on ClinicalTrials.gov